Mass Spectrometry for Peptide Identity: Reading the Mass Spectrum

Every mass spectrometer does the same three things in sequence:

1. Ionization. Mass spectrometers manipulate ions with electric and magnetic fields, so a neutral molecule must first acquire charge. For peptides the standard method is electrospray ionization (ESI): the sample solution is pushed through a fine needle held at high voltage, dispersing it into a spray of charged droplets that evaporate until bare, charged peptide ions remain in the gas phase. ESI is a soft ionization method — it charges molecules without shattering them, which is what makes it suitable for peptides and proteins (Fenn JB, et al. Science. 1989;246(4926):64–71).

2. Mass analysis. The ions are separated according to their mass-to-charge ratio (m/z) — the quantity a mass spectrometer actually measures. This is done by time-of-flight (lighter ions fly faster over a fixed distance), by quadrupole (oscillating fields pass only a selected m/z at a time), or by other analyzer designs.

3. Detection. Ions striking the detector are counted, producing a spectrum: signal intensity plotted against m/z.

The x-axis is not mass — it is mass divided by charge. For a singly charged ion the two are nearly the same, but electrospray typically puts multiple charges on a peptide, usually by protonating basic sites (lysine, arginine, histidine, the N-terminus).

A peptide of mass M carrying n protons appears at:

m/z = (M + n × 1.008) / n

So one molecule produces a family of peaks — the same species at 2+, 3+, 4+ and so on, each at a different m/z. This looks confusing on a raw spectrum and is actually a gift: the spacing between adjacent charge states is a function of the underlying mass, so the whole ladder can be solved back to a single molecular weight. Software does this routinely — deconvolution — and reports one number: the measured molecular mass.

A practical consequence: larger peptides carry more charges and therefore appear at lower m/z than intuition suggests. A 5,000 Da peptide at 5+ shows up near m/z 1,001, well within the range of instruments that would never reach 5,000 in a single-charge world.

Two different molecular weights are reported for the same molecule, and confusing them produces false mismatches.

Monoisotopic mass uses the mass of the most abundant isotope of each element (¹²C exactly 12.000, ¹H 1.00783, and so on). It corresponds to the first peak of an isotope cluster and is what high-resolution instruments report for peptides.

Average mass uses each element's isotope-weighted average atomic mass, reflecting natural isotopic abundance across the whole molecule.

For a small peptide the two differ by a fraction of a dalton; for a 5,000 Da peptide the gap runs to two or three daltons. When a certificate states an expected mass, it should be clear which convention it uses — and a "mismatch" of a couple of daltons on a large peptide is very often just the two conventions being compared to each other.

Higher-resolution instruments also resolve the isotope pattern itself — the small cluster of peaks arising from naturally occurring ¹³C — and the spacing within that cluster reveals charge state directly: peaks 1.0 apart mean 1+, 0.5 apart mean 2+, 0.33 apart mean 3+.

Identity confirmation. Measured mass within tolerance of the calculated mass for the intended sequence is the core result — the evidence that the material is the labeled compound rather than a different peptide.

Common mass discrepancies are diagnostic. Characteristic offsets point at specific problems: +16 Da suggests oxidation (typically at methionine or tryptophan); −18 Da suggests loss of water, or in some contexts a cyclization event; a shortfall matching one residue's mass suggests a deletion sequence — a chain that missed a coupling step during synthesis. A mass that is simply wrong, with no interpretable relationship to the target, means the material is not the intended peptide at all.

Modifications carry their own signatures. Engineered features show up as defined mass additions — a fatty-acid chain on a lipidated analogue, or a linker such as the DAC group discussed in the CJC-1295 comparison. This is why identity testing is the practical way to distinguish two forms of a compound that market listings often conflate.

What MS does not tell you. A mass spectrum confirms molecular weight, not proportion. Two peptides of identical mass — including sequence isomers, the same residues in a different order — are indistinguishable by mass alone; resolving those requires fragmentation (MS/MS), which breaks the peptide along its backbone and reads sequence from the fragment masses. And crucially, MS does not measure how much of the sample is the confirmed species. That is HPLC's job, explained in the companion article on how peptide purity is measured.

HPLC and MS are complementary in the strict sense: neither substitutes for the other, and each covers the other's blind spot.

A certificate carrying both is making two independent claims: this is the right molecule and this is how much of the material it accounts for. Either alone leaves an obvious question open. HEEZ documentation is built on both — independent third-party HPLC purity and mass-spectrometry identity confirmation, with Certificates of Analysis published on product pages as testing is completed. Review the report before you order.